Clinical Trials Logo

Filter by:
NCT ID: NCT02998476 Completed - Lymphoma Clinical Trials

A Phase 2 Safety and Efficacy Study of INCB050465 in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (CITADEL-202)

Start date: March 2, 2017
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess the safety and efficacy of parsaclisib in subjects with relapsed or refractory diffuse large B-cell lymphoma.

NCT ID: NCT02998307 Completed - Simulation Training Clinical Trials

Optimal Training Frequency for Attainment and Maintenance of High-quality CPR on a High-fidelity Manikin

Start date: April 2016
Phase: N/A
Study type: Interventional

Objectives: The primary objective is to determine the least frequent CPR training interval associated with continued performance of guideline-compliant CPR. The secondary objective is to determine whether certain physical characteristics, such as age, gender, exercise tolerance, height, and weight may be able to identify HCPs at high risk of being unable to perform high-quality CPR. Design: Randomized trial to compare the effect of different training frequencies on long-term CPR performance. Participants and setting: Nurses in all adult departments at Health Sciences North. Subjects will be randomly assigned to a group that undertakes short CPR assessment and training sessions either 1) every month, 2) every 3 months, 3) every 6 months, or 4) every 12 months (control group) over the course of a twelve-month period. Analysis: The proportion of nurses in each group that is able to perform "excellent CPR" at the twelve-month time point will be determined. Excellent CPR is defined as a two-minute CPR session where 90% of compressions are performed with correct depth (50-60 mm), 90% with correct rate (100-120 /min), and 90% with full chest recoil. A subgroup analysis will also be performed where the demographic data of individuals who are unable to perform excellent CPR at the twelve-month time point regardless of intervention group are compared against those who are successful. Conclusion: The results of our study will help determine the longest CPR training interval associated with maintenance of high-quality CPR skills to minimize training sessions required and decrease associated costs. The results will also generate hypotheses for future study about optimizing role assignments and team performance in resuscitation.

NCT ID: NCT02998073 Completed - Conduct Disorder Clinical Trials

Investigating Psychosocial Intervention Treatment Response in Justice-Involved Youth With Conduct Disorder

Start date: October 15, 2017
Phase: N/A
Study type: Interventional

This research focuses on youth with conduct disorder (CD), and a history of violence. CD is a youth neurodevelopmental disorder that is commonly associated with criminality. Although psychosocial interventions that address impulsivity and self-control have been shown to be effective at helping promote prosocial behavior in patients with CD, the biological changes that occur as a result of treatment are not well understood. This study will explore changes in the brain function of the anterior cingulate cortex (ACC) in response to a common psychosocial intervention (Stop, Now and Plan). This study will contribute to our understanding of biological mechanisms involved in therapeutic gains among children with behavioural problems and youth offenders; therefore, it will inform further development of treatment programs for children/youth with impulsive behaviours.

NCT ID: NCT02997800 Completed - Heart Rate Clinical Trials

The Effect of Intraoperative Labetalol on Time to Discharge

Start date: November 2012
Phase: Phase 2
Study type: Interventional

Patients coming for surgery often receive opioid medications, like fentanyl, to treat pain. Opioids however have many unpleasant side effects including nausea and vomiting, itching, sedation, and decreased breathing. During laparoscopic surgery increases in heart and blood pressure are often attributed to pain. It has been shown that by treating these changes with medications such as esmolol, instead of opioids, side effects and time to discharge from hospital can be reduced. Labetalol is a drug that is similar to esmolol but may have advantages over it. It is more effective at controlling both heart rate and blood pressure and it is easier and less costly to use. This study is investigating labetalol in patients having laparoscopic gallbladder surgery and comparing it to esmolol and fentanyl. Patients will be treated with one of these drugs during surgery to control heart rate and blood pressure and the effects on time to discharge, pain scores, frequency of side effects, and narcotic requirements will be observed in the recovery room. It is thought that labetalol will be shown to be as effective as esmolol and that both drugs that minimize fentanyl will show reduced time to discharge, fewer side effects, and effective treatment of heart rate and blood pressure.

NCT ID: NCT02997774 Completed - Clinical trials for Haemodialysis Complication

Cooler Dialysis and Liver Perfusion and Function

Start date: February 8, 2017
Phase: N/A
Study type: Interventional

Having hemodialysis affects the blood supply to various organs in the body including the heart and the brain. With time, these effects build up and can affect the way these organs function. The investigators have previously shown that the liver (a key organ which works to help clean the blood, make proteins and turn all your food into energy) is also affected. One of the ways to help protect organs from injury due to dialysis has been cooling during dialysis. The investigators want to examine whether cooling during dialysis protects the blood supply to the liver. CT imaging will be used to measure this blood supply during hemodialysis with standard and cooler settings.

NCT ID: NCT02997631 Completed - Clinical trials for Children Requiring IV Placement

Robot-Based Distraction to Reduce Pain and Distress in the Pediatric Emergency Department

Start date: April 20, 2017
Phase: N/A
Study type: Interventional

Intravenous (IV) insertion is one of the most common procedures for children seeking medical treatment in the Emergency Department (ED). This procedure is often painful and distressing for children and families. This can result in an uncooperative child, a need for multiple cannulation attempts, needle phobia, and dissatisfaction with care for family and healthcare workers. Non-pharmacological treatments are emerging as a newly favoured adjunct to pharmacotherapy, such as distraction therapy. Distraction therapy involves engaging children in cognitive tasks in order to divert attention from painful stimuli and reduce pain and distress. Currently, distraction therapy is not utilized as a standard of care in the ED. Given children's enthusiasm for technological devices, we propose that the use of a technologically enhanced device may be a more effective distractor and may have a greater impact on pain reduction outcomes of patient importance. The primary objective of this study is to compare the reduction of pain and distress with the use of distraction (via the MEDi robot) versus current standard care in children aged 6 to 11 years who are undergoing IV placement.

NCT ID: NCT02997202 Completed - Clinical trials for Acute Myeloid Leukemia

A Trial of the FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients With FLT3/Internal Tandem Duplication (ITD) Acute Myeloid Leukemia (AML)

Start date: June 7, 2017
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare relapse-free survival between participants with FLT3/ITD AML in first morphologic complete remission (CR1) who undergo hematopoietic stem cell transplant (HCT) and are randomized to receive gilteritinib or placebo beginning after the time of engraftment for a two year period.

NCT ID: NCT02997163 Completed - Clinical trials for Advanced Solid Tumors

An Open-Label Pharmacokinetics and Safety Study of Talazoparib

Start date: February 21, 2017
Phase: Phase 1
Study type: Interventional

This trial will investigate the pharmacokinetics (PK) and safety of talazoparib in patients with advanced solid tumors and impaired renal function.

NCT ID: NCT02996903 Completed - Clinical trials for Coronary Artery Disease

Prospective Multicenter Registry On RadiaTion Dose Estimates Of Cardiac CT AngIOgraphy IN Daily Practice in 2017

PROTECTION-VI
Start date: March 1, 2017
Phase:
Study type: Observational [Patient Registry]

The "Prospective Multicenter Registry On RadiaTion Dose Estimates Of Cardiac CT AngIOgraphy IN Daily Practice in 2017" (PROTECTION-VI) study is a prospective registry and investigator-initiated initiative without third-party funding, which will collect and analyze the radiation dose exposure of Cardiac Computed Tomography Angiographic (CCTA) studies in current daily practice worldwide. Particularly, the study will assess the use of strategies for dose reduction during CCTA. A decade ago, the multicentre observational PROTECTION-I study has revealed that the dose-length-product of CCTA ranges between 568 - 1259 mGy x cm with a median of 885 mGy x cm. This corresponds to an estimated effective dose of approximately 12 mSv. Since then a variety of techniques have been developed and enhanced in order to reduce radiation exposure during CCTA. Recent studies demonstrated feasibility of dramatically reduced effective radiation doses during CCTA (0,1 - 0,3 mSv). This has been executed in small cohorts of patients at scientific expert centers. However, it remains unclear, if such low-level radiation dose exposure may be achieved in clinical routine and if diagnostic image quality is maintained. In order to analyze the magnitude of radiation dose exposure of CCTA in today's clinical practice and the current use of dose-saving techniques, we designed the PROTECTION-VI study. Eventually, this study may contribute to further improving radiation dose exposure for patients undergoing CCTA.

NCT ID: NCT02996643 Completed - Clinical trials for Scoliosis; Adolescence

Ultrasound-Assisted Brace Casting for AIS

Start date: January 2012
Phase: Phase 0
Study type: Interventional

Adolescent Idiopathic Scoliosis (AIS) is a three-dimensional deformity of the spine associated with vertebral rotation. Brace treatment is the most commonly used non-surgical treatment. To obtain the best possible outcome, the best in-brace correction within the patient's accepted tolerance must be provided. However, in the existing clinical practice, the immediate in-brace correction cannot be measured during the design and fitting of the brace because the correction is determined using a radiograph. This study is to evaluate the effect of applying ultrasound to measure the stimulated in-brace correction during brace casting.